U.S. Seeks to Block Bankruptcy Plan That Would Free Sacklers From Opioid Claims

The Justice Department has been appealing the deal, approved earlier this month.

Opinion | The Sacklers Are Walking Off Into the Sunset. Reform the System.

The Purdue Pharma bankruptcy case settlement protected the wealthy and ignored those who suffered.

Purdue Pharma Is Dissolved and Sacklers Pay $4.5 Billion to Settle Opioid Claims

The ruling in bankruptcy court caps a long legal battle over the fate of a company accused of fueling the opioid epidemic and the family that owns it.

Sacklers Threaten to Pull Out of Opioid Settlement Without Broad Legal Immunity

In a rare court appearance, David Sackler said he and his family would withdraw their pledge to pay $4.5 billion, unless they are shielded from lawsuits related to Purdue Pharma.

Opinion | In the Opioid Epidemic, More Reasons for Hope Than Despair

After years of dithering and a surge in overdose deaths, we have an administration that seems able to distinguish between effective and ineffective approaches.

15 States Reach a Deal With Purdue Pharma, Advancing a $4.5 Billion Opioids Settlement

The states, including Massachusetts and New York, agreed to drop opposition to the bankruptcy organization plan of the company, the maker of OxyContin.

Major Trial Against Opioid Suppliers Begins in New York

New York’s sweeping lawsuit is the first opioid case in which a jury rather than a judge will decide the outcome.

Judge Clears Purdue Pharma’s Restructuring Plan for Vote by Thousands of Claimants

The ruling was a milestone in yearslong efforts to make the OxyContin manufacturer pay for its role in the opioid crisis, but some plaintiffs feel the plan doesn’t go far enough.